{
    "Trade/Device Name(s)": [
        "Elecsys HSV-2 IgG Immunoassay",
        "Elecsys PreciControl HSV"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K121895",
    "Predicate Device Reference 510(k) Number(s)": [
        "K000238",
        "K081338"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MYF",
        "JJX"
    ],
    "Summary Letter Date": "June 27, 2012",
    "Summary Letter Received Date": "June 29, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3305",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Herpes simplex virus serological assays",
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "virology",
        "immunology"
    ],
    "Analyte(s)": [
        "HSV-2 IgG antibody"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Lithium-heparin plasma",
        "K2-EDTA plasma",
        "K3-EDTA plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Elecsys 2010",
        "MODULAR ANALYTICS E170",
        "cobas e 411",
        "cobas e 601",
        "cobas e 602"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemiluminescent immunoassay",
        "Sandwich immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Elecsys HSV-2 IgG Immunoassay and PreciControl HSV for qualitative detection of HSV-2 IgG antibodies and assay quality control",
    "Indications for Use Summary": "For in vitro qualitative determination of IgG antibodies to HSV-2 in serum and plasma of sexually active individuals and expectant mothers as aid for presumptive diagnosis of HSV-2 infection; PreciControl HSV is for quality control of the Elecsys HSV-2 IgG immunoassay",
    "fda_folder": "Clinical Chemistry"
}